Edgewise Therapeutics, Inc. · NASDAQ:EWTX
Russell Alan J sold 5,901 Edgewise Therapeutics, Inc. shares (Form 4)
Traded Aug 12, 2026 · Filed Aug 14, 2026
On Aug 12, 2026, Russell Alan J (Director, Chief Scientific Officer) sold 5,901 Edgewise Therapeutics, Inc. shares at an average US$43.73 for US$258K, leaving 31,466 shares. Filed Aug 14, 2026 (Form 4).
- Sold
- 5,901 shares
- Price
- US$43.73 average (US$43.68 to US$44.46)
- Value
- US$258K
- Holding after
- 31,466 shares
- Trading plan
- No
- Role
- Director, Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 5,781 | 30,336 | Direct | |
| Aug 12, 2026 | Common Stock | Option exercise | 7,031 | 37,367 | Direct | |
| Aug 12, 2026 | Common Stock | Sale | 3,238 | US$43.68 | 34,129 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 2,273 | US$43.68 | 31,856 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 390 | US$44.46 | 31,466 | Direct |
Source
Related
- Edgewise Therapeutics, Inc.
- Russell Alan J
- Edgewise Therapeutics, Inc. shareholders
- Form 4 · Russell Alan J · Jul 2, 2026
- Form 4 · Fox Jonathan C · Oct 2, 2026
- Form 4 · Donovan Joanne M. · Aug 14, 2026
- Form 4 · Moore John R · Aug 14, 2026
- Form 4 · Derakhshan Behrad · Aug 14, 2026
- Form 4 · Koch Kevin · Aug 14, 2026